Haemoglobin Marseille-Long Island and interpretation of HbA1c: which HbA1c result is the “right answer”?
- Correspondence to: Dr Florkowski; chris.florkowski{at}cdhb.govt.nz
- Received 13 November 2002
- Accepted 19 December 2002
Abstract
A woman was screened for diabetes using glycated haemoglobin (HbA1c). Vastly different results were obtained by high performance liquid chromatography (45%), immunoassay (2.9%), and affinity chromatography (4.2%) compared with the non-diabetic range of less than 6.4%. Mass spectral studies confirmed the presence a haemoglobin variant, haemoglobin Marseille-Long Island which had confounded interpretation by all methods.







